{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:36:40Z","timestamp":1787877400497,"version":"build-2784847793"},"reference-count":96,"publisher":"Elsevier","isbn-type":[{"value":"9780443221781","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016332","name":"Medical Research Center Oulu","doi-asserted-by":"publisher","award":["MRC-01-21-499"],"award-info":[{"award-number":["MRC-01-21-499"]}],"id":[{"id":"10.13039\/100016332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.ircmb.2023.04.004","type":"book-chapter","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T09:07:57Z","timestamp":1689930477000},"page":"149-171","source":"Crossref","is-referenced-by-count":4,"title":["Non-coding RNAs in the epigenetic landscape of cutaneous T-cell lymphoma"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.ircmb.2023.04.004_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ncrna.2016.12.001","article-title":"Non-coding RNAs: A tale of junk turning into treasure","volume":"1","author":"Ahmad","year":"2016","journal-title":"Noncoding RNA Research"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib2","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1158\/0008-5472.CAN-10-0965","article-title":"Phosphoglucose isomerase\/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells","volume":"71","author":"Ahmad","year":"2011","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbcan.2017.01.001","article-title":"Epigenetic basis of cancer health disparities: Looking beyond genetic differences","volume":"1868","author":"Ahmad","year":"2017","journal-title":"Biochimica et Biophysica Acta\u2014Reviews on\u00a0Cancer"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.semcancer.2021.07.015","article-title":"Long non-coding RNAs regulated NF-kappaB signaling in cancer metastasis: Micromanaging by not so small non-coding RNAs","volume":"85","author":"Ahmad","year":"2022","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ncrna.2018.01.001","article-title":"Carcinogenesis in prostate cancer: The role of long non-coding RNAs","volume":"3","author":"Aird","year":"2018","journal-title":"Noncoding RNA Research"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semcancer.2023.04.005","article-title":"Epigenetic programing of cancer stemness by transcription factors-non-coding RNAs interactions","volume":"92","author":"Alsayed","year":"2023","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.omtn.2020.03.003","article-title":"The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics","volume":"20","author":"Bautista-Sanchez","year":"2020","journal-title":"Molecular Therapy. Nucleic Acids"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ncrna.2023.02.006","article-title":"Long non-coding RNAs as promising biomarkers and therapeutic targets in cervical cancer","volume":"8","author":"Begliarzade","year":"2023","journal-title":"Noncoding RNA Research"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ncrna.2022.02.004","article-title":"Long noncoding RNAs as promising biomarkers in cancer","volume":"7","author":"Beylerli","year":"2022","journal-title":"Noncoding RNA Research"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ncrna.2016.11.002","article-title":"Long non-coding RNAs: Mechanism of action and functional utility","volume":"1","author":"Bhat","year":"2016","journal-title":"Noncoding RNA Research"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib11","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jamaoncol.2022.3236","article-title":"Incidence trends of primary cutaneous T-cell lymphoma in the US From 2000 to 2018: A SEER population data analysis","volume":"8","author":"Cai","year":"2022","journal-title":"JAMA Oncology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.4251\/wjgo.v14.i4.748","article-title":"Regulatory RNAs, microRNA, long-non coding RNA and circular RNA roles in colorectal cancer stem cells","volume":"14","author":"Chao","year":"2022","journal-title":"World Journal of Gastrointestinal Oncology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/genes13030539","article-title":"Telomeric repeat-containing RNA (TERRA): A review of the literature and first assessment in cutaneous T-cell lymphomas","volume":"13","author":"Chebly","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ncrna.2020.09.003","article-title":"The physiological function of long-noncoding RNAs","volume":"5","author":"Chen","year":"2020","journal-title":"Noncoding RNA Research"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fgene.2020.00093","article-title":"The oncogenic and tumor suppressive functions of the long noncoding RNA MALAT1: An emerging controversy","volume":"11","author":"Chen","year":"2020","journal-title":"Frontiers in Genetics"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41389-022-00413-7","article-title":"MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms","volume":"11","author":"Chi","year":"2022","journal-title":"Oncogenesis"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib18","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.143.7.854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002","volume":"143","author":"Criscione","year":"2007","journal-title":"Archives of Dermatology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102136","article-title":"Plasma miR-155, miR-203, and miR-205 are biomarkers for monitoring of primary cutaneous T-cell lymphomas","volume":"18","author":"Dusilkova","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ncrna.2021.12.002","article-title":"Scavenging the hidden impacts of non-coding RNAs in multiple sclerosis","volume":"6","author":"Elkhodiry","year":"2021","journal-title":"Noncoding RNA Research"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib21","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3892\/ijo.2017.4006","article-title":"The inhibitory effect of MEG3\/miR-214\/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma","volume":"51","author":"Fan","year":"2017","journal-title":"International Journal of Oncology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3892\/ijo.2020.5162","article-title":"[Retracted] The inhibitory effect of MEG3\/miR-214\/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma","volume":"58","author":"Fan","year":"2021","journal-title":"International Journal of Oncology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122692","article-title":"Epigenetic silencing of tumor suppressor miR-124 directly supports STAT3 activation in cutaneous T-cell lymphoma","volume":"9","author":"Garcia-Colmenero","year":"2020","journal-title":"Cells"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ncrna.2021.08.001","article-title":"Long non-coding RNAs in oncourology","volume":"6","author":"Gareev","year":"2021","journal-title":"Noncoding RNA Research"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.soncn.2006.01.005","article-title":"Cutaneous T-cell lymphoma","volume":"22","author":"Gemmill","year":"2006","journal-title":"Seminars in Oncology Nursing"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12935-022-02754-0","article-title":"A review on the role of mir-16-5p in the carcinogenesis","volume":"22","author":"Ghafouri-Fard","year":"2022","journal-title":"Cancer Cell International"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib27","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1517\/14728222.2014.909807","article-title":"The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer","volume":"18","author":"Ginnebaugh","year":"2014","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000505743","article-title":"MicroRNA-93 targets p21 and promotes proliferation in mycosis fungoides T cells","volume":"237","author":"Gluud","year":"2021","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051229","article-title":"MicroRNAs in the pathogenesis, diagnosis, prognosis and targeted treatment of cutaneous T-cell lymphomas","volume":"12","author":"Gluud","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib30","article-title":"Epigenetic regulation of cutaneous T-cell lymphoma is mediated by dysregulated lncRNA MALAT1 through modulation of tumor microenvironment","volume":"12","author":"Guo","year":"2022","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib31","article-title":"Long non-coding RNAs and the innate immune response. Noncoding","volume":"5","author":"Hadjicharalambous","year":"2019","journal-title":"RNA (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1756-8722-5-9","article-title":"Recent updates on the role of microRNAs in prostate cancer","volume":"5","author":"Hassan","year":"2012","journal-title":"Journal of Hematology & Oncology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib33","first-page":"33","article-title":"Comprehensive landscape and future perspectives of long noncoding RNAs (lncRNAs) in colorectal cancer (CRC): Based on a bibliometric analysis","volume":"8","author":"He","year":"2023"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2010.06.040","article-title":"A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response","volume":"142","author":"Huarte","year":"2010","journal-title":"Cell"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib35","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2013-09-527739","article-title":"MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma","volume":"123","author":"Ito","year":"2014","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib36","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1002\/cam4.2489","article-title":"MicroRNA-124: An emerging therapeutic target in cancer","volume":"8","author":"Jia","year":"2019","journal-title":"Cancer Medicine"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib37","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib38","first-page":"39","article-title":"Tumor suppressive effects of GAS5 in cancer cells","volume":"8","author":"Kaur","year":"2022","journal-title":"Noncoding RNA"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib39","doi-asserted-by":"crossref","first-page":"1015428","DOI":"10.3389\/fonc.2022.1015428","article-title":"LncRNA SNHG6 sponges miR-101 and induces tamoxifen resistance in breast cancer cells through induction of EMT","volume":"12","author":"Khan","year":"2022","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib40","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1038\/onc.2015.435","article-title":"MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas","volume":"35","author":"Kitadate","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045045","article-title":"Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells","volume":"7","author":"Kong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib42","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.4161\/cc.24987","article-title":"STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma","volume":"12","author":"Kopp","year":"2013","journal-title":"Cell Cycle (Georgetown, Tex.)"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.21873\/anticanres.11292","article-title":"Long noncoding RNA PANDA positively regulates proliferation of osteosarcoma cells","volume":"37","author":"Kotake","year":"2017","journal-title":"Anticancer Research"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib44","doi-asserted-by":"crossref","first-page":"34","DOI":"10.20892\/j.issn.2095-3941.2020.0216","article-title":"Epigenetics of cutaneous T-cell lymphoma: Biomarkers and therapeutic potentials","volume":"18","author":"Lai","year":"2021","journal-title":"Cancer Biology & Medicine"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib45","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1182\/blood-2012-04-423061","article-title":"Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts","volume":"120","author":"Lee","year":"2012","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib46","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood-2017-06-788950","article-title":"Prognostic miRNA classifier in early-stage mycosis fungoides: Development and validation in a Danish nationwide study","volume":"131","author":"Lindahl","year":"2018","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib47","doi-asserted-by":"crossref","first-page":"45730","DOI":"10.18632\/oncotarget.10160","article-title":"STAT5 induces miR-21 expression in cutaneous T cell lymphoma","volume":"7","author":"Lindahl","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib48","doi-asserted-by":"crossref","first-page":"adv00270","DOI":"10.2340\/00015555-3574","article-title":"MicroRNA-106b regulates expression of the tumour suppressors p21 and TXNIP and promotes tumour cell proliferation in mycosis fungoides","volume":"100","author":"Lindahl","year":"2020","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib49","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd4140","article-title":"MicroRNAs and other non-coding RNAs as targets for anticancer drug development","volume":"12","author":"Ling","year":"2013","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib50","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.4161\/15384101.2014.947759","article-title":"Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines","volume":"13","author":"Litvinov","year":"2014","journal-title":"Cell Cycle (Georgetown, Tex.)"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib51","first-page":"3027","article-title":"miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10","volume":"42","author":"Liu","year":"2018","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ncrna.2017.04.002","article-title":"The essentiality of non-coding RNAs in cell reprogramming","volume":"2","author":"Luginbuhl","year":"2017","journal-title":"Noncoding RNA Research"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib53","article-title":"Mechanisms of circRNA\/lncRNA-miRNA interactions and applications in disease and drug research","volume":"162","author":"Ma","year":"2023","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"Spec No 1","key":"10.1016\/bs.ircmb.2023.04.004_bib54","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1093\/hmg\/ddl046","article-title":"Non-coding RNA","volume":"15","author":"Mattick","year":"2006","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib55","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1158\/1078-0432.CCR-11-1192","article-title":"IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma","volume":"17","author":"Miyagaki","year":"2011","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib56","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ncrna.2020.11.004","article-title":"Long non-coding RNAs in breast cancer metastasis","volume":"5","author":"Mondal","year":"2020","journal-title":"Noncoding RNA Research"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib57","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/exd.12161","article-title":"miR-155 is involved in tumor progression of mycosis fungoides","volume":"22","author":"Moyal","year":"2013","journal-title":"Experimental Dermatology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib58","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/bjd.15422","article-title":"Oncogenic role of microRNA-155 in mycosis fungoides: An in vitro and xenograft mouse model study","volume":"177","author":"Moyal","year":"2017","journal-title":"The British Journal of Dermatology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib59","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1186\/s12885-018-4845-0","article-title":"N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer","volume":"18","author":"Mrozik","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib60","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1073\/pnas.1918167117","article-title":"The functional activity of E-cadherin controls tumor cell metastasis at multiple steps","volume":"117","author":"Na","year":"2020","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.32","article-title":"MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sezary syndrome","volume":"2","author":"Narducci","year":"2011","journal-title":"Cell Death & Disease"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib62","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0002-9440(10)65028-6","article-title":"p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides","volume":"156","author":"Navas","year":"2000","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib63","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.4161\/15384101.2014.965061","article-title":"Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression","volume":"13","author":"Netchiporouk","year":"2014","journal-title":"Cell Cycle (Georgetown, Tex.)"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib64","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/stem.1922","article-title":"Concise review: Custodians of the transcriptome: how microRNAs guard stemness in squamous epithelia","volume":"33","author":"Ning","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2019.194417","article-title":"Non-coding RNA regulatory networks","volume":"1863","author":"Panni","year":"2020","journal-title":"Biochimica et Biophysica Acta\u2014Gene Regulatory Mechanisms"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib66","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/apm.12186","article-title":"miRNA in mycosis fungoides and skin inflammation","volume":"121","author":"Persson","year":"2013","journal-title":"APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib67","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cll.2017.06.006","article-title":"Cutaneous T-cell lymphoma","volume":"37","author":"Pulitzer","year":"2017","journal-title":"Clinics in Laboratory Medicine"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib68","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1182\/blood-2011-06-358382","article-title":"Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)","volume":"118","author":"Ralfkiaer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib69","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/nat.2020.0861","article-title":"Novel MicroRNA sponges to specifically modulate gene expression in colon cancer cells","volume":"30","author":"Rama","year":"2020","journal-title":"Nucleic Acid Therapeutics"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043531","article-title":"TMEM244 is a long non-coding RNA necessary for CTCL cell growth","volume":"24","author":"Rassek","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib71","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1158\/0008-5472.CAN-14-3613","article-title":"CASC15-S is a tumor suppressor lncRNA at the 6p22 neuroblastoma susceptibility locus","volume":"75","author":"Russell","year":"2015","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib72","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCRESAHA.113.301865","article-title":"Decoding noncoding RNA: Da Vinci redux?","volume":"113","author":"Sandberg","year":"2013","journal-title":"Circulation Research"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib73","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjh.15547","article-title":"Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma","volume":"183","author":"Seto","year":"2018","journal-title":"The British Journal of Haematology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib74","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.jid.2018.03.1500","article-title":"MicroRNA signatures in diagnosis and prognosis of cutaneous T-cell lymphoma","volume":"138","author":"Shen","year":"2018","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib75","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib76","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00412-018-0659-8","article-title":"Ki-67: More than a proliferation marker","volume":"127","author":"Sun","year":"2018","journal-title":"Chromosoma"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib77","article-title":"MicroRNAs and their signaling pathway in mycosis fungoides","volume":"101","author":"Sun","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224305","article-title":"Potential role for microRNA-16 (miR-16) and microRNA-93 (miR-93) in diagnosis and prediction of disease progression in mycosis fungoides in Egyptian patients","volume":"14","author":"Talaat","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib79","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/jid.2010.349","article-title":"MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sezary syndrome","volume":"131","author":"van der Fits","year":"2011","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib80","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.molonc.2011.02.003","article-title":"miRNA expression profiling of mycosis fungoides","volume":"5","author":"van Kester","year":"2011","journal-title":"Molecular Oncology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib81","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib82","first-page":"450","article-title":"GAS5 attenuates the malignant progression of glioma stem-like cells by promoting E-cadherin","volume":"30","author":"Wang","year":"2023","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib83","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.1002\/jcp.26833","article-title":"MicroRNA-16 functions as a tumor-suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2","volume":"233","author":"Wang","year":"2018","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib84","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.3390\/ijms23105679","article-title":"The functions of PCNA in tumor stemness and invasion","volume":"23","author":"Wang","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib85","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/leu.2011.81","article-title":"The role of microRNA-150 as a tumor suppressor in malignant lymphoma","volume":"25","author":"Watanabe","year":"2011","journal-title":"Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K."},{"key":"10.1016\/bs.ircmb.2023.04.004_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.752817","article-title":"The role of microRNA in pathogenesis, diagnosis, different variants, treatment and prognosis of mycosis fungoides","volume":"11","author":"Wen","year":"2021","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib87","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/ajh.22139","article-title":"Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management","volume":"86","author":"Wilcox","year":"2011","journal-title":"The American Journal of Hematology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib88","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/ajh.24876","article-title":"Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management","volume":"92","author":"Wilcox","year":"2017","journal-title":"The American Journal of Hematology"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib89","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib90","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib91","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1038\/s41388-018-0571-y","article-title":"miR-155 drives oncogenesis by promoting and cooperating with mutations in the c-Kit oncogene","volume":"38","author":"Witten","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib92","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1080\/15384101.2019.1629789","article-title":"miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway","volume":"18","author":"Xia","year":"2019","journal-title":"Cell Cycle (Georgetown, Tex.)"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib93","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.molcel.2010.03.021","article-title":"Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a","volume":"38","author":"Yap","year":"2010","journal-title":"Molecular Cell"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib94","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fgene.2015.00145","article-title":"Long noncoding RNAs: A potential novel class of cancer biomarkers","volume":"6","author":"Yarmishyn","year":"2015","journal-title":"Frontiers in Genetics"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib95","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ncrna.2022.06.003","article-title":"Two lncRNAs, MACC1-AS1 and UCA1, co-mediate the expression of multiple mRNAs through interaction with individual miRNAs in breast cancer cells","volume":"7","author":"Zhang","year":"2022","journal-title":"Noncoding RNA Research"},{"key":"10.1016\/bs.ircmb.2023.04.004_bib96","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/CBM-181675","article-title":"MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1","volume":"23","author":"Zhu","year":"2018","journal-title":"Cancer Biomarkers: Section A of Disease Markers"}],"container-title":["International Review of Cell and Molecular Biology","Epigenetic Regulation of Cancer - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644823000618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644823000618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T15:11:32Z","timestamp":1753456292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1937644823000618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780443221781"],"references-count":96,"URL":"https:\/\/doi.org\/10.1016\/bs.ircmb.2023.04.004","relation":{},"ISSN":["1937-6448"],"issn-type":[{"value":"1937-6448","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}